Anyone can throw numbers around, how about these numbers:...

First 1051 Last

Share
Profile

Follow
SprayandWipe

497 Posts.

22

28/04/20

13:15

Post #: 44300848
Share

Originally posted by Immetoday ↑

I'm pretty happy with yesterdays ann's.

Maria didn't get 'some Indian lab test'.......that 'Indian lab test' was actually carried out by an accredited by WHO laboratory and had nothing to do with Cellmid.

There's plenty of info out there at the moment but I've learnt that stories from outlets like New Delhi TV aren't always the best to place your bets on......if you're a fan of their journalistic integrity then that's up to you, I prefer lab reports and detail being provided by people who are in the business.

I'm not expecting anything re tests until Doherty Institute finish their review - I don't know why you'd put something out there until you have the Fed Gov's own funded review as support for your product. From the vast majority of reports I've read Wondfu tests are at the top of the class and so I expect that will be reflected by the Doherty Institute.

My expectation is the next ann will be a ripper and give us a very clear picture of where things are headed on the test front........I'm expecting it will be positive all the way.

Just a note - 12,000 tests have already been commercially sold according to what I've read.....there has been no bad publicity regarding those units in Aus has there? The government (according to the CHO) has 'recently taken delivery' of some antibody tests and are waiting on the remainder of their 1.5 mil they have on order so they can distribute to GP's. (I'm not saying that these are CDY tests but timelines fit)

I've seen tests are quoted at between $20-$30 each.....lets say we average that at $25 x 1.5 mil tests.......$37.5 mil revenue as an initial order........just imagine what that will do to the share price if it was CDY that supplied them.

Don't forget, that's just the initial order.......there is talk of testing all Australians....even with a healthy bulk discount, lets say we sell for $15 each......28 million x $15 - $420 mil....hang on though.....didn't I read everyone will require 2 x tests? ......I'm getting dizzy

Expand

Anyone can throw numbers around, how about these numbers:

Yer dizzying

CDY Price at posting: 21.8¢ Sentiment: Hold Disclosure: Not Held
4 Upvote

0 Great analysis

Reply

Top Stories

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

HotCopper Highlights: Your most watched stocks for Week 46, 2024

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

First 1051 Last

Add AN1 (ASX) to my watchlist

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $3.690M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Anyone can throw numbers around, how about these numbers:...

Banshee's historic trenches prove rich in antimony and gold for GDM

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Cyclone signs MOU with Vale for development of Iron Bear play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Featured News

Featured News

Anyone can throw numbers around, how about these numbers:...

Top Stories

Banshee's historic trenches prove rich in antimony and gold for GDM

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Cyclone signs MOU with Vale for development of Iron Bear play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Featured News

Featured News